The ways in which pharmaceutical companies market their drugs directly to consumers in the U.S. could face quite the evolution in 2025—at least, if legislators and other government powers have ...
On September 16, 2025, the U.S. Food and Drug Administration (FDA) released more than 60 warning letters sent to specific pharmaceutical manufacturers, alleging misbranding of a particular drug ...
The bill would only prohibit direct-to-consumer advertising of approved prescription pharmaceuticals and biologics, sparing medical devices, dietary supplements, cosmetics, over-the-counter drugs, ...
President Donald Trump on Tuesday signed a memo to rein in direct-to-consumer advertising for prescription drugs on television, social media, and other platforms. The memo directs the Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback